Mitral Regurgitation News and Research

RSS

Mitral valve replacement may provide better long-term correction of mitral regurgitation

The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation -- mitral valve repair and mitral valve replacement.

21 Nov 2013

Research provides first rigorous comparison of 2 surgical approaches for severe heart valve disease

New research presented today at the 2013 Scientific Sessions of the American Heart Association by researchers at the Perelman School of Medicine at the University of Pennsylvaniafound no difference in outcomes at one-year between two recommended surgical options for treating ischemic mitral regurgitation (IMR) - repair of the leaky valve or its replacement with an artificial valve.

20 Nov 2013

Study examines two surgical approaches for treatment of severe ischemic mitral regurgitation

The Cardiothoracic Surgical Trials Network, whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation -- mitral valve repair and mitral valve replacement.

19 Nov 2013

New procedure repairs the mitral valve in patients at high risk for open heart surgery

A minimally invasive procedure is the first effective treatment for patients who are high risk for standard open heart surgery for a leaking heart valve, a study led by a University of Virginia School of Medicine researcher has found.

14 Nov 2013

Neovasc's Tiara transcatheter mitral valve replacement technology gets US patent

Neovasc Inc. today announced that the first patent covering the company's innovative Tiara transcatheter mitral valve replacement technology has been issued by the US Patent and Trademark Office.

13 Nov 2013

Middle Peak Medical raises additional $3M in Series A financing

Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M.

28 Oct 2013

Early surgery offers long-term survival, lowers risk of heart failure in mitral valve regurgitation patients

Patients with severe mitral valve regurgitation who are otherwise healthy should have mitral valve repair surgery sooner rather than later, even if they feel no symptoms, a Mayo Clinic-led study by U.S. and European researchers found.

14 Aug 2013

Abbott announces data from MitraClip system study on mitral regurgitation

Abbott today announced data from the EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High Surgical Risk cohort evaluating the company's first-in-class catheter-based MitraClip System for the treatment of mitral regurgitation (MR).

11 Mar 2013

Abbott Vascular designates Montreal Heart Institute as a Center of Excellence

The Montreal Heart Institute has just been designated as a Center of Excellence by Abbott Vascular for the percutaneous treatment of mitral valve failure with their MitraClip system. The MHI has therefore become a reference centre for this procedure for all hospitals across Canada and many other hospitals in North America.

29 Jan 2013

Cardiac Dimensions commences commercialization of CARILLON mitral contour system in Europe

Cardiac Dimensions, Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON Mitral Contour System under its Conformite Europeenne (CE) Mark approval.

29 Sep 2012

Complete mitral valve ring repair reduces recurrent regurgitation

Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.

10 Sep 2012

Neovasc first quarter revenues increase 46% to $1,712,991

Neovasc Inc., today announced financial results for the three months ended March 31, 2012.

29 May 2012

Patients with mitral regurgitation live longer after surgery

Patients with mitral regurgitation, a type of valvular heart disease common in the elderly, are living longer after surgery, Yale School of Medicine researchers report in the journal Circulation: Cardiovascular Quality and Outcomes.

11 May 2012

MHI cardiologists perform first clinical procedure in Canada using MitraClip system

The interventional cardiology team at the Montreal Heart Institute (MHI) recently conducted the first clinical procedure in Canada using the MitraClip system, which is designed to treat patients suffering from mitral valve failure, a very common heart defect that affects an estimated 1 out 5 people to various extents starting at the age of 55.

16 Dec 2011

NYU Langone cardiovascular experts present new research findings at AHA 2011

Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.

18 Nov 2011

Cardiac Dimensions' enhanced version of CARILLON system receives CE Mark approval

Cardiac Dimensions, Inc. today announced that it has received Conformite Europeenne (CE) Mark approval for a newly enhanced version of its CARILLON Mitral Contour System, a novel therapy for treating heart failure patients suffering from functional mitral regurgitation.

30 Sep 2011

MitraClip treatment could benefit heart failure patients who are unresponsive to CRT

Results of an observational study presented at the European Society of Cardiology (ESC) meeting today in Paris demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with mitral regurgitation (MR), who do not respond to cardiac resynchronization therapy.

29 Aug 2011

Symposium papers highlight role of oxidative stress in cardiovascular disease

Recent years have seen major advances in understanding of the health effects of oxidative stress—including its potential to cause injury to the cardiovascular system. A series of expert updates on the role of oxidative stress in heart failure, atherosclerosis, and other cardiovascular diseases appears in a special symposium in the August issue of The American Journal of the Medical Sciences, official journal of the Southern Society for Clinical Investigation.

26 Jul 2011

Transcatheter valve replacement safe and effective alternative to open-heart surgery

An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery.

27 Jun 2011

Cardiac Dimensions initiates two CARILLON device trials in Functional Mitral Regurgitation

Cardiac Dimensions, Inc. announced today the initiation of two new clinical studies using the CARILLON Mitral Contour System, an investigational device for percutaneous treatment of Functional Mitral Regurgitation.

4 May 2011